Asensus Surgical, Inc.
Asensus Surgical, Inc. (ASXC) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
asxc · pe ratio · data through Dec 31, 2023
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Asensus Surgical, Inc. (ASXC) measures how much investors pay for each dollar of the company's trailing earnings. ASXC's current PE ratio of N/A is calculated by dividing its stock price of $0.35 by its TTM earnings per share of -$0.31.
Source: FMP · /ratios-ttm · /analyst-estimates · 2023-12-31
PE Ratio History
2004 – 2023 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Medical - Devices · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Asensus Surgical, Inc.You ASXC | $95M | N/A | — | -$0.31 |
 Aadi Bioscience, Inc. AADI | $95M | N/A | — | -$0.03 |
 Berkeley Lights, Inc. BLI | $87M | N/A | — | -$1.42 |
 iCAD, Inc. ICAD | $106M | N/A | — | -$0.21 |
 Insight Molecular Diagnostics Inc. IMDX | $154M | N/A | — | -$1.65 |
 Jounce Therapeutics, Inc. JNCE | $99M | N/A | — | -$0.99 |
 Miromatrix Medical Inc. MIRO | $93M | N/A | — | -$1.45 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2023-12-31Latest FY2023 | — | $-0.31 | — | |
2022-12-31 FY2022 | — | $-0.32 | — | |
2021-12-31 FY2021 | — | $-0.28 | — | |
2020-12-31 FY2020 | — | $-0.84 | — | |
2019-12-31 FY2019 | — | $-8.69 | — | |
2018-12-31 FY2018 | — | $-3.88 | — | |
2017-12-31 FY2017 | — | $-0.97 | — | |
2016-12-31 FY2016 | — | $-1.07 | — | |
2015-12-31 FY2015 | — | $-0.59 | — | |
2014-12-31 FY2014 | — | $-0.64 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Asensus Surgical, Inc. (ASXC) measures how much investors pay for each dollar of the company's trailing earnings. ASXC's current PE ratio of N/A is calculated by dividing its stock price of $0.35 by its TTM earnings per share of -$0.31.
Frequently asked questions
ASXC pe ratio · 6 questionsASXC's current PE ratio is N/A as of 2026-06-09, based on a stock price of $0.35 and TTM EPS of -$0.31. Data sourced from Financial Modeling Prep via ASXC's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Asensus Surgical, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09